Prelude Therapeutics Incorporated (PRLD)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 49
-0.11
-1.9643%
After Hours
$
+0.48 +8.7432% 5. 97
318.82M Market Cap
- P/E Ratio
- Div Yield
538,437 Volume
-2 Eps
$ 5.6
Previous Close 
Want to track PRLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Prelude Therapeutics Incorporated (PRLD) Statistics
Valuation metrics
Market Cap 318.82M
Enterprise value 302.74M
Trailing P/E (ttm) -6.92
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 13.89
Price/Book (mrq) 4.02
Enterprise Value/Revenue 13.5
Enterprise Value/EBITDA -5.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 725K
Average volume (90 days) 464.34K
Price summary
52-Week low 0.98
52-Week high 6.83
Beta -
50-Day moving average 4.7
200-Day moving average 3.85
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.7%
Operating margin -3.01%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.75%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.23
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.54
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 4.07%
Book value per share (mrq) 1.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
